Geoffrey works in the Faculty of Medicine, Nursing & Health Sciences at Monash University as a Clinical Associate Professor.
Littlejohn, G.O., Farrell, J., 1999, Pain,Nature of Task, and Body Part Used in Fibromyalgia Syndrome, in Muscle Pain, Myofascial Pain, and Fibromyalgia, The Haworth Medical Press, Binghamton NY USA, pp. 279-284.
Montag, K., Gingold, M., Boers, A.J., Littlejohn, G.O., 2011, Disease-modifying anti-rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community-based practice, Internal Medicine Journal [P], vol 41, issue 6, Wiley-Blackwell Publishing Asia, Australia, pp. 450-455.
Chappell, A.S., Littlejohn, G.O., Kajdasz, D.K., Scheinberg, M., D'Souza, D., Moldofsky, H., 2009, A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia, Clinical Journal of Pain [P], vol 25, issue 5, Lippincott Williams & Wilkins, United States, pp. 365-375.
Littlejohn, G.O., Guymer, E.K., 2009, Fibromyalgia: Mechanisms and management, Medicine Today [P], vol 10, issue 10, Medicine Today Pty. Ltd, Australia, pp. 16-26.
Guymer, E.K., Littlejohn, G.O., 2009, Fibromyalgia: current diagnosis and management, Australasian Chiropractic & Osteopathy [P], vol 5, issue 2, Expert Reviews Ltd, United Kingdom, pp. 181-192.
Buchbinder, R., Barber, M.N., Heuzenroeder, L., Wluka, A.E., Giles, G.G., Hall, S., Harkness, A., Lewis, D., Littlejohn, G.O., Miller, M., Ryan, P.F.J., Jolley, D.J., 2008, Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate, Arthritis and Rheumatism, vol 59, issue 6, John Wiley & Sons, Inc., United States, pp. 794-799.
Li, Q., Sahhar, J.M., Littlejohn, G.O., 2008, Red flags in scleroderma, Australian Family Physician [P], vol 37, issue 10, Royal Australian College of General Practitioners, Australia, pp. 831-834.
Guymer, E.K., Littlejohn, G.O., 2007, Fibromyalgia: top down or bottom up?, International Journal of Rheumatic Diseases [P], vol 10, issue 3, Wiley-Blackwell Publishing Asia, Australia, Singapore, pp. 174-177.
Walker, J.G., Littlejohn, G.O., 2007, Measuring quality of life in rheumatic conditions, Clinical Rheumatology, vol 26, Springer, USA, pp. 671-673.
Littlejohn, G.O., Guymer, E.K., 2006, Fibromyalgia syndrome: which antidepressant drug should we choose, Current Pharmaceutical Design, vol 12, issue 1, Bentham Science Publishers, Netherlands, pp. 3-9.
Guymer, E.K., Littlejohn, G.O., 2006, Fibromyalgia: Towards mechanism-targeted therapy, Medicine Today [P], vol 7, issue 11, Medicine Today Pty. Ltd, Australia, pp. 26-40.
Wluka, A., Buchbinder, R., Hall, S., Littlejohn, G.O., Grennan, D.M., Gray, J., 2002, Methtrexate and postoperative complications, Annals of the Rheumatic Diseases: the EULAR journal, vol 61, issue 1, B M J Group, United Kingdom, pp. 86-87.
Littlejohn, G.O., Morand, E.F., 2002, Rheumatology, Medical Journal of Australia, vol 176, issue 1, Australasian Medical Publishing Company Ltd, Sydney NSW Australia, p. 41.
Leech, M., Littlejohn, G.O., 2000, Inflammatory arthritis and fibromyalgia rationate for early intervention, Current Therapeutics, vol 41 issue 2, Adis Press Australasia, Balgewlah Australia, pp. 16-21.
Walker, J.G., Littlejohn, G.O., McMurray, N.E., Cutolo, M., 1999, Stress system response and rheumatoid arthritis: a multilevel approach, Rheumatology, vol 38, Oxford University Press, Oxford UK, pp. 1050-1057.
Johns, K.R., Littlejohn, G.O., 1999, The Safety and Efficacy of Cyclosporine (Neoral) in Rheumatoid Arthritis, Journal of Rheumatology, vol 26 (10), Journal Rheumatology Publishing Co, Toronto Canada, pp. 2110-2113.
Kipen, Y., Briganti, E.M., Strauss, B.J.G., Will, R., Littlejohn, G.O., Morand, E.F., 1999, Three Year Followup of Bone Mineral Density Change in Premenopausal Women with Systemic Lupus Erythematosus, Journal of Rheumatology, vol 26 (2), Journal Rheumatology Publising Co, Toronto Canada, pp. 310-317.
Kipen, Y., Briganti, E.M., Strauss, B.J., Will, R., Littlejohn, G.O., Morand, E.F., 1999, Three year follow up of bone mineral density change in premenopausal women with systematic lupus erythematosus, The Journal of Rheumatology, vol 26 issue 2, The Journal of Rheumatology Publishing Co ltd, Toronto Canada, pp. 310-317.
Kipen, Y., Briganti, E.M., Strauss, B.J.G., Littlejohn, G.O., Morand, E.F., 1999, Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus, Rheumatology, vol 38, Oxford University Press, Oxford UK, pp. 59-65.
Littlejohn, G.O., 1998, Fibromyalgia syndrome and disability: the Neurogenic model, Medical Journal of Australia, vol 168 no 20 l, Australasian Medical Publishing Company Ltd, www.mja.com.au/, pp. 398-401.
Hawkey, C., Kahan, A.M., Steinbruck, K., Alegre, C., Baumelou, E., Begaud, B., Dequeker, J., Isomaki, H., Littlejohn, G.O., Mau, J., Papazoglou, S., Melissa Study Grp, I., 1998, Gastrointestinal Tolerability of Meloxicam Compared to Diclofenac in Osteoarthritis Patients, British Journal of Rheumatology, vol 37, Oxford University Press, Oxford UK, pp. 937-945.
Dequeker, J., Hawkey, C., Kahan, A.M., Steinbruck, K., Alegre, C., Baumelou, E., Begaud, B., Isomaki, H., Littlejohn, G.O., Mau, J., Papazoglou, S., 1998, Improvement in Gastrointestinal Tolerability of the Selective Cyclooxygenase (Cox)-2 Inhibitor, Meloxicam, Compared with Piroxicam: Results of the Safety and Efficacy Large-Scale Evaluation of Cox-Inhibiting Therapies (Select) Trial In Osteoarthritis, British Journal of Rheumatology, vol 37, Oxford University Press, Oxford UK, pp. 946-951.
Littlejohn, G.O., 1998, Management of Fibromyalgia Syndrome, Current Therapeutics, vol 39 august, Adis International Pty Ltd, 9 Rodborough Rd Frenchs Forest NSW 2086, pp. 53-65.
Johns, K.R., Morand, E.F., Littlejohn, G.O., 1998, Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases, Australian New Zealand Journal of Medicine, vol 28, The Royal Australasian College of Physician, Sydney NSW Australia, pp. 18-22.
Sahhar, J.M., Littlejohn, G.O., 1998, The Role of Tetracycline in Treating Rheumatoid Arthritis, Current Therapeutics, vol 39 no 9, Adis International Pty Ltd, 9 Rodborough Rd Frenchs Forest NSW 2086, pp. 47-57.
Johns, K.R., Littlejohn, G.O., 1998, The antiphospholipid antibody syndrome, Australian Family Physician, vol 27 no 8, Journal of the Royal Australian College of GP's, South Melbourne Vic Australia, pp. 709-713.
Kipen, Y., Littlejohn, G.O., Morand, E.F., 1997, Methotrexate use in systemic lupus erythematosus, Lupus, vol 6, Stockton Press, England UK, pp. 385-389.
Kipen, Y., Buchbinder, R., Forbes, A.B., Strauss, B.J., Littlejohn, G.O., Morand, E.F., 1997, Prevalance of reduced bone mineral density in Systemic Lupus Erythematosus and the role of steroids, Journal of Rheumatology, vol 24, Journal of Rheumatology Publishing Co, Toronto Canada, pp. 1922-1929.
Kipen, Y., Buchbinder, R., Forbes, A.B., Strauss, B.J.G., Littlejohn, G.O., Morand, E.F., 1997, Prevalence of Reduced Bone Mineral Density in Systemic Lupus Erythematosus and the Role of Steroids, The Journal of Rheumatology, vol 24, Journal of Rheumatology Publishing Co Ltd, Toronto Canada, pp. 1922-1929.
Johns, K.R., Xu, J., Littlejohn, G.O., 1998, Efficacy and tolerability of neoral in inflammatory polyarthritis, Australian Rheumatology Association, Sydney 23-27 May 1998, The Australian Rheumatology Association, Sydney NSW Australia, p. 739.
Farrell, J., Littlejohn, G.O., 1998, Fewer tender points needed to measure sensitivity change in FM, Australian Rheumatology Association, Sydney 23-27 May 1998, The Australian Rheumatology Association, Sydney NSW Australia, p. 750.
Kipen, Y., Briganti, E.M., Strauss, B.J.G., Will, R., Littlejohn, G.O., Morand, E.F., 1998, Follow up study of bone mineral density in systemic lupus erythematosus, Australian Rheumatology Association, Sydney 23-27 May 1998, The Australian Rheumatology Association, Sydney NSW Australia, p. 732.
Wluka, A., Buchbinder, R., Mylvaganam, A., Hall, S., Harkness, A., Lewis, D., Littlejohn, G.O., Miller, M., Ryan, P., 1998, Long term methotrexate use in rheumatoid arthritis: 12 Year follow up of 460 patients, Australian Rheumatology Association, Sydney 23-27 May 1998, The Australian Rheumatology Association, Sydney NSW Australia, p. 740.
Johns, K.R., Littlejohn, G.O., 1998, Pain Threshold Mood and Stress Variation During the menstrual cycle, Journal of Muscoloskeletal Pain, Silvi Marina Italy Aug 24-27, Haworth Medical Press, Italy, p. 166.
Farrell, J., Littlejohn, G.O., 1998, Pain Threshold, Pain and the workplace, Journal of Musculoskeletal Pain, Silvi Marina Italy Aug 24-27, Haworth Medical Press, Italy, p. 110.
Farrell, J., Littlejohn, G.O., 1998, Pain, Nature of task and body part used in FMS, Journal of Musculosketal Pain, Silvi Marina Italy Aug 24-27, Haworth Medical Press, Italy, p. 109.
Farrell, J., Littlejohn, G.O., 1998, Quantifying Comparing and contrasting the physical content of normal tasks to improve treatment by activity participation and rehabilitation outcomes, Sharing a global perspective, Montreal Canada May 31-June 5, World Federation of Occupational Therapists, Montreal Canada, p. D2.11.
Farrell, J., Littlejohn, G.O., 1998, Task alteration, pain and work production in fibromyalgia, Premus-Iseoh 1998, Helsinki Finland 21-25 September, Finnish Institute of Occupational Health, Helsinki, p. 145.
Craven, R., Johns, K.R., Littlejohn, G.O., 1998, The Association of Oestrogen with Rheumatic Symptoms and Pain Threshold in Perimenopausal Women, Australian Rheumatology Association, Sydney 23-27 May 1998, The Australian Rheumatology Association, Sydney NSW Australia, p. 732.
Farrell, J., Littlejohn, G.O., 1998, Tool Holding and Chronic Musculoskeletal Pain, Sharing a global perspective, Montreal Canada May 31-June 5, World Federation of Occupational Therapists, Montreal Canada, p. C1.09.
Authorised by: Director, Office of Marketing and Communications.
Maintained by: eSolutions ServiceDesk.
Last updated: 18 February 2013.
Copyright © 2013 Monash University. ABN 12 377 614 012 -
Accessibility -
Caution -
Privacy
CRICOS Provider Number: 00008C
We acknowledge and pay respects to the Elders and Traditional Owners of the land on which our six Australian campuses stand. Information for Indigenous Australians
